What is the recommended dose and administration timing for basal insulin, such as Lantus (glargine) or Levemir (detemir)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Basal Insulin Administration and Dosing

Basal insulin should be initiated at 0.1-0.2 units/kg/day or 10 units once daily, administered at the same time each day, with dose adjustments based on fasting blood glucose levels. 1, 2

Initial Dosing

The recommended starting dose for basal insulin depends on the patient's clinical situation:

  • Type 2 diabetes (insulin-naive):

    • 0.1-0.2 units/kg/day or 10 units once daily 3, 1, 4
    • For patients with higher insulin resistance (obesity, infections, open wounds): Consider 0.3-0.4 units/kg/day 5
    • For patients with increased sensitivity (elderly, renal/hepatic impairment): Lower to 0.1 units/kg/day 3, 5
  • Type 1 diabetes:

    • Approximately one-third of total daily insulin requirements as basal insulin 1
    • Must be used with prandial insulin 1

Administration Timing

  • Administer subcutaneously once daily at the same time every day 1
  • For insulin detemir (Levemir):
    • Can be administered once or twice daily 2
    • Once-daily: Administer with evening meal or at bedtime 2
    • Twice-daily: Administer morning dose and evening dose 12 hours apart 2

Injection Sites

  • Administer subcutaneously into:
    • Abdominal area
    • Thigh
    • Upper arm (deltoid) 1
  • Rotate injection sites within the same region to reduce risk of lipodystrophy 1

Dose Titration

Titration should be based on fasting blood glucose measurements:

  • Simple titration rule:

    • Increase dose by 2 units every 3-7 days if fasting glucose remains above target 3, 4
    • Decrease dose by 2 units if fasting glucose falls below 80 mg/dL (4.4 mmol/L) 3
  • Target fasting glucose:

    • General target: 80-130 mg/dL (4.4-7.2 mmol/L) 4
    • For older adults or those with comorbidities: 90-150 mg/dL (5.0-8.3 mmol/L) 3

Avoiding Common Pitfalls

  1. Overbasalization:

    • Avoid continuing to escalate basal insulin beyond 0.5-1.0 units/kg/day without improvement in fasting glucose 4
    • If basal dose exceeds 0.5 units/kg/day with suboptimal control, consider adding prandial insulin or GLP-1 receptor agonist 3
  2. Hypoglycemia risk:

    • Increase monitoring frequency during dose adjustments 1
    • Use lower starting doses in elderly, those with renal/hepatic impairment, or poor oral intake 3
  3. Switching between basal insulins:

    • When switching from NPH to glargine: Use same total daily dose 1
    • When switching from twice-daily NPH to once-daily glargine: Use 80% of total NPH dose 1
    • When switching from twice-daily detemir/glargine to degludec: Consider 10-20% dose reduction 6

Special Considerations

  • Hospitalized patients:

    • For patients on continuous enteral feeding: Consider dividing total daily dose into every 8-hour administration 5
    • For surgical patients: Give 60-80% of usual basal insulin dose on day of surgery 3
  • Older adults:

    • Consider simplified regimen with once-daily basal insulin
    • Target higher fasting glucose (90-150 mg/dL) 3
    • Avoid bedtime rapid-acting insulin 3

Remember that basal insulin should be titrated gradually over weeks to achieve target fasting glucose levels, with careful attention to hypoglycemia risk and individual patient factors.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin management of diabetic patients on general medical and surgical floors.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.